Efficacy and Safety of SBRT Plus Gemcitabine, Cisplatin, and Sintilimab as First-Line Treatment for Unresectable Biliary Tract Cancer
Clinical trial NCT07638501 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07638501
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-15
- Primary completion
- 2028-06-15
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.